Telehealth Interventions for Caregiver Well-being
(WellCAST Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to identify which telehealth treatments best support caregivers of individuals with rare neurogenetic conditions. It will test various programs, such as individual therapies, group sessions, and peer coaching, to determine what meets caregivers' needs. Participants will provide feedback through surveys to help match people with the right support. Caregivers in the U.S. seeking mental health support while caring for someone with a genetic condition affecting the brain may be a good fit. As an unphased study, this trial offers caregivers the chance to contribute to research that could significantly enhance support systems for others in similar situations.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are actively in treatment that overlaps with the trial's offerings, you may not be eligible to participate.
What prior data suggests that these telehealth interventions are safe for caregivers?
Research shows that telehealth programs are generally safe and well-received by caregivers. Studies have found that these programs can significantly enhance caregivers' well-being without major safety concerns. Telehealth services, which include programs to boost participation, effectively provide support and education to caregivers, leading to better outcomes.
While telehealth can sometimes make people feel like they have more to manage, research indicates it usually alleviates this feeling. Although some might feel overwhelmed, most find telehealth support helpful and manageable. Overall, telehealth treatments for caregivers have a strong safety record, making them a dependable option for those seeking support.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how telehealth interventions can enhance caregiver well-being using a mix of behavioral therapies and innovative algorithms. Unlike traditional face-to-face therapy, this approach leverages digital platforms to deliver therapies like Acceptance and Commitment Therapy and Dialectical Behavioral Therapy, potentially reaching more caregivers more conveniently. The trial's innovative use of personalized algorithms aims to tailor interventions based on individual needs, which could make support more effective and adaptive than standard methods. By integrating culturally informed practices and self-guided resources, this trial also addresses diverse caregiver needs, offering a holistic approach to mental health support.
What evidence suggests that this trial's telehealth interventions could be effective for caregiver well-being?
Research has shown that several telehealth treatments can effectively help caregivers of people with rare genetic brain conditions. This trial studies Acceptance and Commitment Therapy (ACT), which reduces stress by encouraging acceptance of feelings and focusing on personal values. Culturally Informed Cognitive Behavioral Therapy (CICBT) is another treatment option, adapting traditional therapy to cultural needs, thus enhancing its effectiveness for caregivers from diverse backgrounds. Dialectical Behavioral Therapy (DBT) is also under evaluation for its ability to help manage emotions and reduce caregiver stress. Additionally, interventions like the Participation Enhancement Intervention, which have been found to lower caregiver stress and boost confidence, are part of this trial. These treatments aim to provide flexible support and improve caregiver well-being through personalized telehealth programs.678910
Who Is on the Research Team?
Bridgette Kelleher, PhD
Principal Investigator
Purdue University
Are You a Good Fit for This Trial?
This trial is for caregivers and legal guardians of children aged 2-35 with neurogenetic conditions that cause moderate to severe intellectual disability. Participants must live in the US, be fluent in English, and seek support for their mental health or caregiving needs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Caregivers complete initial study forms and 'snapshot surveys' sent three times per day via smartphones
Treatment
Participants complete a 12-week telehealth support program, which may include self-guided resources, individual therapies, group therapies, and/or peer-to-peer coaching
Follow-up
Participants complete follow-up forms and a 2-week period of 'snapshot surveys' to assess changes post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Acceptance and Commitment Therapy (ACT)
- Culturally Informed Cognitive Behavioral Therapy (CICBT)
- Dialectical Behavioral Therapy (DBT)
- Durand Sleep Intervention
- Naturalistic Communication Intervention (NCI)
- Participation Enhancement Intervention (PEI)
- RUBI Intervention
- Self-Guided Resources
Find a Clinic Near You
Who Is Running the Clinical Trial?
Purdue University
Lead Sponsor
University of Virginia
Collaborator
University of Canterbury
Collaborator
University of Oregon
Collaborator
Georgia State University
Collaborator
University of Missouri-Columbia
Collaborator
Indiana University
Collaborator